CoreWeave

CoreWeave, Dell, and Diamondback insiders sold $100M+ in 2026, but sales are declining, aligned with buybacks, or follow private equity timelines.

CoreWeave lands multi-year GPU deal with Perplexity amid 50% stock decline, signaling continued AI infrastructure demand despite market concerns about spending slowdown.

Class action filed against CoreWeave ($CRWV) alleging executives made false statements about operational capabilities and customer demand fulfillment between March-December 2025. Lead plaintiff deadline: March 13, 2026.

CoreWeave posts 168% revenue growth to $5.1B with $66.8B backlog, guiding to $12-13B 2026 revenue, backed by IBM and OpenAI partnerships.

CoreWeave hit $5.1B revenue in 2025, up 168%, but swung to $46M operating loss amid $1.2B interest expenses and heavy Nvidia dependence.

CoreWeave faces securities fraud lawsuit alleging misstatements about customer demand capacity, supplier reliance, and financial risks during March-December 2025 class period.

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability, resulting in earnings miss and weak guidance.

CoreWeave faces securities class action over false demand statements and concealed supplier concentration risk. March 13, 2026 deadline for affected investors.

CoreWeave's Perplexity deal validates shift from AI training to inference workloads. $66.8B backlog and $30-35B 2026 capex support analyst targets of $124.34.

Class action lawsuit alleges CoreWeave made materially false statements about demand and supplier risks between March-December 2025. Lead plaintiff deadline: March 13, 2026.

CoreWeave ($CRWV) faces securities class action lawsuit alleging false demand statements and understated supplier risks. Lead plaintiff deadline: March 13, 2026.

$CRWV faces class action suit alleging misleading statements about customer demand and vendor concentration risks. Investors who bought shares between March-December 2025 can join lawsuit.

CoreWeave investors have until March 13, 2026, to join securities fraud class action alleging misrepresented demand and concealed construction delays that triggered 16% stock decline.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and concealed business risks during 2025, following merger collapse and infrastructure delays.

Coatue Management exited CoreWeave with 80% gains, reallocating capital toward a new Moderna position ahead of the biotech stock's 50% rally.

CoreWeave investors have until March 13, 2026 to join securities lawsuit alleging material misstatements about operational capacity and supplier risks.

CoreWeave's stock surged 120% post-IPO as AI demand boosts GPU rental services. The company faces profitability risks despite strong revenue growth and Nvidia backing.

Class action lawsuit filed against CoreWeave for allegedly making false statements about operational capabilities and customer demand fulfillment. Investors who purchased stock during specified period may seek lead plaintiff status.

CoreWeave faces securities fraud lawsuit alleging false statements about operational capabilities and supplier risks. March 13, 2026 deadline set for investors to claim lead plaintiff status.

CoreWeave, an AI infrastructure provider serving Meta, Microsoft, and OpenAI, is valued at 10x sales with $55.6 billion revenue backlog and projected 136% growth in 2026.